Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study

Alice Y Chang, June Oshiro, Colby Ayers, Richard J. Auchus

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective Polycystic ovarian syndrome (PCOS) is estimated to affect up to 20% of women. PCOS is associated with insulin resistance and cardiovascular (CV) risk factors. We aimed to evaluate the impact of race/ethnicity on the prevalence of CV risk factors and subclinical predictors of CV events. Design Cross-sectional analysis of data collected by the Dallas Heart Study, an urban, population-based cohort oversampled for blacks. Patients A previously described cohort of women with PCOS and control subjects of the same racial/ethnic group, matched for age and body mass index. Measurements Hormonal and clinical measures associated with PCOS and CV risk factors. Results The study included 117 women with PCOS and 204 controls. Women with PCOS had significant differences across racial/ethnic groups in the prevalence of hypertension, hypercholesterolaemia, hypertriglyceridaemia and impaired fasting glucose (P < 0·05). Controls showed significant racial/ethnic differences in the prevalence of hypertension and impaired fasting glucose (P < 0·05). The odds of hypertension were significantly greater among women with PCOS than controls after adjusting for race/ethnicity (odds ratio, 1·50 [95% CI, 1·03-2·30]; P = 0·04). However, we did not see an interaction of race/ethnicity that significantly changed CV risk factor prevalence between PCOS and controls. In addition, subclinical measures of CV disease were not different between women with PCOS vs controls, even among hypertensive women. Conclusions Race/ethnicity affects the prevalence of CV risk factors for women with and without PCOS. However, race/ethnicity does not interact with PCOS to additionally increase CV risk factor prevalence or subclinical CV disease.

Original languageEnglish (US)
Pages (from-to)92-99
Number of pages8
JournalClinical Endocrinology
Volume85
Issue number1
DOIs
StatePublished - Jul 1 2016

Fingerprint

Polycystic Ovary Syndrome
Hypertension
Ethnic Groups
Fasting
Cardiovascular Diseases
Glucose
Urban Population
Hypertriglyceridemia
Hypercholesterolemia
Insulin Resistance
Body Mass Index
Cross-Sectional Studies
Odds Ratio

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study. / Chang, Alice Y; Oshiro, June; Ayers, Colby; Auchus, Richard J.

In: Clinical Endocrinology, Vol. 85, No. 1, 01.07.2016, p. 92-99.

Research output: Contribution to journalArticle

@article{5b61671bdfb94c3fbffe2635e3e6ee87,
title = "Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study",
abstract = "Objective Polycystic ovarian syndrome (PCOS) is estimated to affect up to 20{\%} of women. PCOS is associated with insulin resistance and cardiovascular (CV) risk factors. We aimed to evaluate the impact of race/ethnicity on the prevalence of CV risk factors and subclinical predictors of CV events. Design Cross-sectional analysis of data collected by the Dallas Heart Study, an urban, population-based cohort oversampled for blacks. Patients A previously described cohort of women with PCOS and control subjects of the same racial/ethnic group, matched for age and body mass index. Measurements Hormonal and clinical measures associated with PCOS and CV risk factors. Results The study included 117 women with PCOS and 204 controls. Women with PCOS had significant differences across racial/ethnic groups in the prevalence of hypertension, hypercholesterolaemia, hypertriglyceridaemia and impaired fasting glucose (P < 0·05). Controls showed significant racial/ethnic differences in the prevalence of hypertension and impaired fasting glucose (P < 0·05). The odds of hypertension were significantly greater among women with PCOS than controls after adjusting for race/ethnicity (odds ratio, 1·50 [95{\%} CI, 1·03-2·30]; P = 0·04). However, we did not see an interaction of race/ethnicity that significantly changed CV risk factor prevalence between PCOS and controls. In addition, subclinical measures of CV disease were not different between women with PCOS vs controls, even among hypertensive women. Conclusions Race/ethnicity affects the prevalence of CV risk factors for women with and without PCOS. However, race/ethnicity does not interact with PCOS to additionally increase CV risk factor prevalence or subclinical CV disease.",
author = "Chang, {Alice Y} and June Oshiro and Colby Ayers and Auchus, {Richard J.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1111/cen.12986",
language = "English (US)",
volume = "85",
pages = "92--99",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study

AU - Chang, Alice Y

AU - Oshiro, June

AU - Ayers, Colby

AU - Auchus, Richard J.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Objective Polycystic ovarian syndrome (PCOS) is estimated to affect up to 20% of women. PCOS is associated with insulin resistance and cardiovascular (CV) risk factors. We aimed to evaluate the impact of race/ethnicity on the prevalence of CV risk factors and subclinical predictors of CV events. Design Cross-sectional analysis of data collected by the Dallas Heart Study, an urban, population-based cohort oversampled for blacks. Patients A previously described cohort of women with PCOS and control subjects of the same racial/ethnic group, matched for age and body mass index. Measurements Hormonal and clinical measures associated with PCOS and CV risk factors. Results The study included 117 women with PCOS and 204 controls. Women with PCOS had significant differences across racial/ethnic groups in the prevalence of hypertension, hypercholesterolaemia, hypertriglyceridaemia and impaired fasting glucose (P < 0·05). Controls showed significant racial/ethnic differences in the prevalence of hypertension and impaired fasting glucose (P < 0·05). The odds of hypertension were significantly greater among women with PCOS than controls after adjusting for race/ethnicity (odds ratio, 1·50 [95% CI, 1·03-2·30]; P = 0·04). However, we did not see an interaction of race/ethnicity that significantly changed CV risk factor prevalence between PCOS and controls. In addition, subclinical measures of CV disease were not different between women with PCOS vs controls, even among hypertensive women. Conclusions Race/ethnicity affects the prevalence of CV risk factors for women with and without PCOS. However, race/ethnicity does not interact with PCOS to additionally increase CV risk factor prevalence or subclinical CV disease.

AB - Objective Polycystic ovarian syndrome (PCOS) is estimated to affect up to 20% of women. PCOS is associated with insulin resistance and cardiovascular (CV) risk factors. We aimed to evaluate the impact of race/ethnicity on the prevalence of CV risk factors and subclinical predictors of CV events. Design Cross-sectional analysis of data collected by the Dallas Heart Study, an urban, population-based cohort oversampled for blacks. Patients A previously described cohort of women with PCOS and control subjects of the same racial/ethnic group, matched for age and body mass index. Measurements Hormonal and clinical measures associated with PCOS and CV risk factors. Results The study included 117 women with PCOS and 204 controls. Women with PCOS had significant differences across racial/ethnic groups in the prevalence of hypertension, hypercholesterolaemia, hypertriglyceridaemia and impaired fasting glucose (P < 0·05). Controls showed significant racial/ethnic differences in the prevalence of hypertension and impaired fasting glucose (P < 0·05). The odds of hypertension were significantly greater among women with PCOS than controls after adjusting for race/ethnicity (odds ratio, 1·50 [95% CI, 1·03-2·30]; P = 0·04). However, we did not see an interaction of race/ethnicity that significantly changed CV risk factor prevalence between PCOS and controls. In addition, subclinical measures of CV disease were not different between women with PCOS vs controls, even among hypertensive women. Conclusions Race/ethnicity affects the prevalence of CV risk factors for women with and without PCOS. However, race/ethnicity does not interact with PCOS to additionally increase CV risk factor prevalence or subclinical CV disease.

UR - http://www.scopus.com/inward/record.url?scp=84952685577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952685577&partnerID=8YFLogxK

U2 - 10.1111/cen.12986

DO - 10.1111/cen.12986

M3 - Article

VL - 85

SP - 92

EP - 99

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 1

ER -